Henry Schein Inc (NAS:HSIC)
$ 77.05 -0.61 (-0.79%) Market Cap: 9.61 Bil Enterprise Value: 12.47 Bil PE Ratio: 31.58 PB Ratio: 2.75 GF Score: 84/100

Henry Schein Inc at Nasdaq Investor Conference Transcript

Dec 06, 2023 / 10:00AM GMT
Release Date Price: $70.62 (+1.06%)
Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst

Good morning, everyone. I'll start with some disclosures first. So please see the Morgan Stanley website for more details on the disclosure at morganstanley.com/disclosures.

But to introduce myself, I'm Erin Wright. I'm the lead health care services analyst at Morgan Stanley. We're happy to have Henry Schein with us. I do cover them. They are the leading dental and medical distributor globally. And we're happy to have with us Stanley Bergman, CEO of Henry Schein; as well as the CFO, Ron South. So thank you. Thank you for coming to London.

Questions & Answers

Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst

So let's start with just a general question that we're getting from a lot of investors right now is just the state of the dental market. Globally, if you can talk about kind of the different geographies as well but North America versus other markets. But what you're seeing in terms of patient traffic trends and demand?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot